Research on correlation between tumor-stroma ratio and prognosis in non-small cell lung cancer

被引：3
|
作者：
Zhang, Xueqing [1 ]
Zhang, Yan [1 ]
Sun, Zongwen [1 ]
Ma, Huiping [1 ]
机构：
[1] Jining 1 Peoples Hosp, Dept Resp Med, 6 Hlth Rd, Jining 272011, Shandong, Peoples R China
来源：
MINERVA MEDICA | 2019年 / 110卷 / 06期
关键词：
D O I：
10.23736/S0026-4806.19.06001-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：590 / 592
页数：4
相关论文
共 50 条
  • [1] Periostin and tumor-stroma interactions in non-small cell lung cancer
    Nitsche, Ulrich
    Stangel, Daniela
    Pan, Zheng
    Schlitter, Anna Melissa
    Esposito, Irene
    Regel, Ivonne
    Raulefs, Susanne
    Friess, Helmut
    Kleeff, Joerg
    Erkan, Mert
    [J]. ONCOLOGY LETTERS, 2016, 12 (05) : 3804 - 3810
  • [2] Predictive Role of Tumor-Stroma Ratio for Survival of Patients With Non-Small Cell Lung Cancer: A Meta-Analysis
    Zhang, Xuefeng
    Ma, Hongfu
    Zhang, Liang
    Li, Fenghuan
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2022, 27
  • [3] Tumor-stroma ratio (TSR) in non-small cell lung cancer (NSCLC) patients after lung resection is a prognostic factor for survival
    Xi, Ke-Xing
    Wen, Ying-Sheng
    Zhu, Chong-Mei
    Yu, Xiang-Yang
    Qin, Rong-Qing
    Zhang, Xue-Wen
    Lin, Yong-Bin
    Rong, Tie-Hua
    Wang, Wei-Dong
    Chen, Yong-Qiang
    Zhang, Lan-Jun
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (10) : 4017 - 4026
  • [4] Effects of pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer
    Ayako Fujiwara
    Soichiro Funaki
    Eriko Fukui
    Kenji Kimura
    Takashi Kanou
    Naoko Ose
    Masato Minami
    Yasushi Shintani
    [J]. Scientific Reports, 10
  • [5] Effects of pirfenidone targeting the tumor microenvironment and tumor-stroma interaction as a novel treatment for non-small cell lung cancer
    Fujiwara, Ayako
    Funaki, Soichiro
    Fukui, Eriko
    Kimura, Kenji
    Kanou, Takashi
    Ose, Naoko
    Minami, Masato
    Shintani, Yasushi
    [J]. SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Effects of Pirfenidone Targeting EMT and Tumor-Stroma Interaction as Novel Treatment for Non-Small Cell Lung Cancer
    Fujiwara, A.
    Shintani, Y.
    Funaki, S.
    Kawamura, T.
    Kanzaki, R.
    Fukui, E.
    Minami, M.
    Okumura, M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1948 - S1949
  • [7] The individuality of tumor-stroma interaction in non-small cell lung cancer: insights from functional and molecular analyses
    Gottschling, Sandra
    Kuner, Ruprecht
    Granzow, Martin
    Jauch, Anna
    Xu, Chang Elizabeth
    Muley, Thomas
    Hoffmann, Hans
    Dienemann, Hendrik
    Eckstein, Volker
    Ho, Anthony D.
    Herth, Felix F.
    Thomas, Michael
    Meister, Michael
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S388 - S388
  • [8] Correlation between survivin expression and prognosis in non-small cell lung cancer
    Atikcan, S
    Ünsal, E
    Demirag, F
    Köksal, D
    Yilmaz, A
    [J]. CHEST, 2005, 128 (04) : 332S - 332S
  • [9] Correlation between survivin expression and prognosis in non-small cell lung cancer
    Atikcan, Sukran
    Unsal, Ebru
    Demirag, Funda
    Koksal, Deniz
    Yilmaz, Aydin
    [J]. RESPIRATORY MEDICINE, 2006, 100 (12) : 2220 - 2226
  • [10] Impact of Tumor-Stroma Ratio on the Prognosis of Colorectal Cancer: A Systematic Review
    Gao, Jinlai
    Shen, Zhangguo
    Deng, Zaixing
    Mei, Lina
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
12345